MENU
+Compare
ABBV
Stock ticker: NYSE
AS OF
Nov 13, 04:59 PM (EDT)
Price
$232.35
Change
-$0.88 (-0.38%)
Capitalization
410.55B

ABBV ABBVIE Forecast, Technical & Fundamental Analysis

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta)... Show more

ABBV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ABBV with price predictions
Nov 12, 2025

ABBV in upward trend: price rose above 50-day moving average on November 11, 2025

ABBV moved above its 50-day moving average on November 11, 2025 date and that indicates a change from a downward trend to an upward trend. In of 36 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ABBV's RSI Indicator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 12, 2025. You may want to consider a long position or call options on ABBV as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ABBV just turned positive on November 12, 2025. Looking at past instances where ABBV's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ABBV advanced for three days, in of 369 cases, the price rose further within the following month. The odds of a continued upward trend are .

ABBV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 10-day moving average for ABBV crossed bearishly below the 50-day moving average on November 06, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABBV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ABBV entered a downward trend on November 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ABBV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ABBV's P/B Ratio (243.902) is very high in comparison to the industry average of (9.612). ABBV's P/E Ratio (175.977) is considerably higher than the industry average of (23.835). Projected Growth (PEG Ratio) (0.417) is also within normal values, averaging (2.037). Dividend Yield (0.028) settles around the average of (0.028) among similar stocks. ABBV's P/S Ratio (6.906) is slightly higher than the industry average of (3.560).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

View a ticker or compare two or three
ABBV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ABBV is expected to report earnings to rise 80.65% to $3.36 per share on February 04

ABBVIE ABBV Stock Earnings Reports
Q4'25
Est.
$3.36
Q3'25
Beat
by $0.08
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.10
The last earnings report on October 31 showed earnings per share of $1.86, beating the estimate of $1.78. With 7.97M shares outstanding, the current market capitalization sits at 410.55B.
A.I.Advisor
published Dividends

ABBV paid dividends on November 14, 2025

ABBVIE ABBV Stock Dividends
А dividend of $1.64 per share was paid with a record date of November 14, 2025, and an ex-dividend date of October 15, 2025. Read more...
A.I. Advisor
published General Information

General Information

a research-based pharmaceutical company

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1 North Waukegan Road
Phone
+1 847 932-7900
Employees
50000
Web
http://www.abbvieinvestor.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RSPD55.740.21
+0.38%
Invesco S&P 500® Equal Wt Cnsm Disc ETF
SCHD27.190.01
+0.04%
Schwab US Dividend Equity ETF™
APCB29.930.01
+0.03%
ActivePassive Core Bond ETF
SIXZ29.38-0.01
-0.02%
AllianzIM US Lrg Cp 6M Bfr10 May/Nov ETF
TAFL25.22-0.09
-0.35%
AB Tax-Aware Long Municipal ETF

ABBV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABBV has been loosely correlated with PFE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ABBV jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABBV
1D Price
Change %
ABBV100%
+3.58%
PFE - ABBV
58%
Loosely correlated
+1.41%
AMGN - ABBV
50%
Loosely correlated
-0.64%
NVS - ABBV
47%
Loosely correlated
+1.37%
BIIB - ABBV
47%
Loosely correlated
+1.20%
GSK - ABBV
43%
Loosely correlated
-0.70%
More